Loading...

Solanbridge Group, Inc.

SLNX•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)
U.S. Market opens in 11h 8m

Solanbridge Group, Inc. (SLNX) Stock Overview

Explore Solanbridge Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap476K
P/E Ratio-7.14
EPS (TTM)N/A
ROE1.18%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

SLNX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Solanbridge Group, Inc. (SLNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.14 and a market capitalization of 476K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
400.000%
1-Month Change
400.000%
3-Month Change
400.000%
6-Month Change
400.000%
Year-to-Date (YTD) Change
400.000%
1-Year Change
400.000%
3-Year Change
-50.00%
5-Year Change
-87.50%
All-Time (Max) Change
-99.96%

Contact Information

https://www.solanbridgegroup.com
832-225-1372
9595 Six Pines Drive, The Woodlands, TX, 77380

Company Facts

IPO DateJun 29, 2007
CountryUS
Actively Trading

Frequently Asked Questions